Skip to content

Company information lookup


The Company is a specialty pharmaceutical company focused on the development and commercialisation of new pain management and abuse prevention products.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
QRX 0.019 0% 0.019 0.020 0.019 0.019 0.019 42,275


Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code QRX
Official Listing Date 25 May, 2007
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address
Registered Office Address Level 11, Suite 1, 100 Walker Street, NORTH SYDNEY, NSW, AUSTRALIA, 2060
Head Office Telephone (02) 8404 4139
Head Office Fax (02) 8920 0314
Share Registry Telephone 1300 554 474
Directors / Senior Management
Dr Edward Rudnic (CEO)
Mr Bruce Hancox (Director)
Dr Richard Treagus (Director)
Mr Chris J Campbell (CFO)
Company Secretary Mr Chris J Campbell
Principal Activities The Company is a specialty pharmaceutical company focused on the development and commercialisation of new pain management and abuse prevention products.

QRXPHARMA LTD announcements

How are company announcements published on

Date Price
Headline Pages PDF
29/10/2014   Results of 2014 Annual General Meeting 1 PDF
29/10/2014   Chairman's Address to Shareholders 3 PDF
24/10/2014 asterix Appendix 4C - Quarter Ended 30 September 2014 5 PDF
26/09/2014   Annual Report to Shareholders - 2014 69 PDF
26/09/2014   Notice of 2014 Annual General Meeting and Proxy Form 10 PDF
28/08/2014   2014 Annual General Meeting - Wednesday, 29 October 2014 1 PDF
27/08/2014 asterix Preliminary Final Report - 30 June 2014 74 PDF
14/08/2014 asterix QRxPharma Halts Moxduo Development 2 PDF
31/07/2014   QRxPharma General Shareholder Update 2 PDF
17/07/2014 asterix Appendix 4C - Quarter Ended 30 June 2014 7 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
25 Nov 2014 0.019 0% 0.020 0.019 158,400
24 Nov 2014 0.019 18.75% 0.019 0.016 660,708
21 Nov 2014 0.016 0% 0.019 0.015 116,160
20 Nov 2014 0.016 -5.88% 0.016 0.016 45,570
19 Nov 2014 0.017 0% 0.017 0.017 69,100

* Volume of shares shown represents only those shares traded on ASX.

QRXPHARMA LTD price history chart

* More charting options are available.


How are dividends released on

No dividends have been found for the security QRX. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security QRX

Warrants & Structured Products

No warrants & Structured Products are available over the security QRX